AVTX-008

N/A

Report date: 2025/07/04 16:55:25

Base Information

Drug NameAVTX-008
Drug Alias NameAVTX-008CERC-008
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionB- and T-lymphocyte attenuator agonists
TargetsB- and T-lymphocyte attenuator
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesAvalo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A